Suchergebnisse - (Person:"Scaroni, Carla")

PubPharm (7)

1

Central adrenal insufficiency : open issues regarding diagnosis and glucocorticoid treatment

enthalten in: Clinical chemistry and laboratory medicine | 2019

von Ceccato, F. | Scaroni, C.

2

Decrease in salivary cortisol levels after glucocorticoid dose reduction in patients with adrenal insufficiency : A prospective proof-of-concept study

enthalten in: Clinical endocrinology | 2018

von Ceccato, F. | Barbot, M. | Lizzul, L. | +6

3

Glucose Metabolism Abnormalities in Cushing Syndrome : From Molecular Basis to Clinical Management

enthalten in: Endocrine reviews | 2017

von Scaroni, C. | Zilio, M. | Foti, M. | +1

4

Long-term glucocorticoid effect on bone mineral density in patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency

enthalten in: European journal of endocrinology | 2016

von Ceccato, F. | Barbot, M. | Albiger, N. | +8

5

The diagnostic performance of urinary free cortisol is better than the cortisol:cortisone ratio in detecting de novo Cushing's syndrome : the use of a LC-MS/MS method in routine clinical practice

enthalten in: European journal of endocrinology | 2014

von Ceccato, F. | Antonelli, G. | Barbot, M. | +8

6

Assessment of glucocorticoid therapy with salivary cortisol in secondary adrenal insufficiency

enthalten in: European journal of endocrinology | 2012

von Ceccato, F. | Albiger, N. | Reimondo, G. | +6

7

Microsatellite (GT)(n) is part of the von Willebrand factor (VWF) promoter region that influences the glucocorticoid-induced increase in VWF in Cushing's syndrome

enthalten in: Thrombosis research | 2010

von Daidone, V. | Pontara, E. | Romualdi, C. | +5

1
[1]